To request a FREE 2-week trial subscription, please signup. NOTE - this can take up to 48hrs to be approved.

29 April 2025 EWHC ruling discusses application of EPO case law regarding lack of plausibility and lack of technical contribution | Court had earlier overturned a first-instance decision allowing an ...

After almost 30 years as head of IP at Bayer, Jörg Thomaier is to retire and is handing the baton to Dorian Immler. Speaking ...

31 March 2025 With billions in revenue at stake, the pharma giant has a 27-country parallel litigation effort to protect its blockbuster blood thinner from generics. Marisa Woutersen finds Bayer’s ...

This LSPN panel features experts from Maiwald, Regeneron, Vertex Pharmaceuticals, and Taylor Wessing discussing the impact of ...

The Arusha Protocol is a catalyst for agricultural transformation. It provides legal assurance and financial incentives for plant breeders, enabling access to improved, protected varieties that ...

California medical device company sues rival at the ITC and in Delaware court over “copycat” brain monitoring system launch ...

Janssen filed patent infringement suits in New Jersey and Delaware over proposed copy of blockbuster drug Invega Sustenna | Lawsuits follow appeals court win for J&J in separate action with Teva and ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...

For startups, getting a drug to market is a marathon but founders need to think beyond filing patents to win over investors, ...

4 February 2025 LSIPR sister title WIPR releases USA Patents Rankings, divided into categories of non-contentious and ...

LSPN panellists from Mathys & Squire discuss recent developments affecting the EPO Boards of Appeal and decisions emerging ...